Clinical handbook of psychotropic drugs:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Ashland, OH [u.a.]
Hogrefe
2007
|
Ausgabe: | 17., completely rev. ed. |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | 380 S. graph. Darst. |
ISBN: | 9780889373457 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV023107060 | ||
003 | DE-604 | ||
005 | 20170705 | ||
007 | t | ||
008 | 080130s2007 xxud||| |||| 00||| eng d | ||
015 | |a 07,A37,0826 |2 dnb | ||
016 | 7 | |a 985233907 |2 DE-101 | |
020 | |a 9780889373457 |c spiralgeh. : EUR 54.95 |9 978-0-88937-345-7 | ||
035 | |a (OCoLC)255600546 | ||
035 | |a (DE-599)DNB985233907 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
044 | |a xxu |c XD-US |a sz |c XA-CH | ||
049 | |a DE-355 |a DE-578 | ||
082 | 0 | |a 615.788 |2 22/ger | |
082 | 0 | |a 615.788 | |
084 | |a CZ 2000 |0 (DE-625)19239: |2 rvk | ||
084 | |a XI 5800 |0 (DE-625)153018:12905 |2 rvk | ||
084 | |a QV 77.2 |2 nlm | ||
084 | |a 610 |2 sdnb | ||
245 | 1 | 0 | |a Clinical handbook of psychotropic drugs |c Kalyna Z. Bezchlibnyk-Butler, principal ed. ... |
246 | 1 | 3 | |a Psychotropic drugs |
250 | |a 17., completely rev. ed. | ||
264 | 1 | |a Ashland, OH [u.a.] |b Hogrefe |c 2007 | |
300 | |a 380 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 4 | |a Psychopharmakon | |
650 | 0 | 7 | |a Psychopharmakon |0 (DE-588)4047729-0 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Bezchlibnyk-Butler, Kalyna Z. |d 1947- |e Sonstige |0 (DE-588)121257649 |4 oth | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016309721&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-016309721 |
Datensatz im Suchindex
_version_ | 1814336509083385856 |
---|---|
adam_text |
Antidepressants 2
Selective Serotonin Reuptake Inhibitors (SSRI) 3
Norepinephrine Dopamine Reuptake Inhibitor
(NDRI) 16
Selective Serotonin Norepinephrine Reuptake
Inhibitor (SNRI) 21
Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) 27
Noradrenergic/Specific Serotonergic
Antidepressants (NaSSA) 33
Non-Selective Cyclic Antidepressants 37
Monoamine Oxidase Inhibitors 46
Reversible Inhibitor of MAO-A (RIMA) 46
Irreversible Monoamine Oxidase Inhibitors 50
Monoamine Oxidase B Inhibitor 56
Effects of Antidepressants on
Neurotransmitters/Receptors 59
Pharmacological Effects of Antidepressants
on Neurotransmitters/Receptors 60
Frequency of Adverse Reactions to Cyclic
Antidepressants at Therapeutic Doses 61
Frequency (%) of Adverse Reactions to MAOI
Antidepressants at Therapeutic Doses 63
Antidepressant Doses and Pharmacokinetics 64
Switching Antidepressants 66
Antidepressant Augmentation Strategies 68
Electroconvulsive Therapy (ECT) 71
Bright-Light Therapy (BLT) 77
Repetitive Transcranial Magnetic
Stimulation (rTMS) 79
Antipsychotics (Neuroleptics) 82
"Second-Generation" Antipsychotics/SGAs
(Neuroleptics) 88
"Third-Generation" Antipsychotic/TGA
(Neuroleptics) 103
"First Generation" Antipsychotics/FGAs 106
Effects of Antipsychotics on
Neurotransmitters/Receptors 117
fABLE of Contents
Pharmacological Effects of Antipsychotics
on Neurotransmitters/Receptors 118
Frequency (%) of Adverse Reactions to
Antipsychotics at Therapeutic Doses 119
Antipsychotic Doses and Pharmacokinetics 121
Comparison of Depot Antipsychotics 126
Extrapyramidal Side Effects of Antipsychotics 128
Switching Antipsychotics 131
Antipsychotic Augmentation Strategies 133
Agents for Treating Extrapyramidal
Side Effects 136
Effects on Extrapyramidal Symptoms 141
Comparison of Agents for Treating
Extrapyramidal Side Effects 142
Anxiolytic Agents 145
Benzodiazepines 145
Comparison of the Benzodiazepines 154
Buspirone 159
Hypnotics/Sedatives 162
Comparison of Hypnotics/Sedatives 168
Mood Stabilizers 173
Lithium 173
Anticonvulsants 182
Comparison of Anticonvulsants 185
Comparison of Adverse Reactions to
Mood Stabilizers at Therapeutic Doses 203
L-Tryptophan 204
Drugs for ADHD 206
Psychostimulants 206
Atomoxetine 214
Comparison of Drugs for ADHD 217
Clonidine 221
Augmentation Strategies in ADHD 224
Drugs for Treatment of Dementia 225
Cholinesterase Inhibitors 225
Memantine 231
Comparison of Drugs for Treatment of Dementia 233
Sex-Drive Depressants 236
Comparison of Sex-Drive Depressants 238
Drugs of Abuse 240
Alcohol 243
Stimulants 247
Hallucinogens 252
Opiates/Narcotics 259
Inhalants/Aerosols 263
Gamma Hydroxy Butyrate (GHB)/Sodium Oxybate 265
Flunitrazepam (Rohypnol) 267
Treatment of Substance Use Disorders 268
Disulfiram 268
Acamprosate 271
Naltrexone 273
Methadone 276
Buprenorphine 280
New Unapproved Treatments
of Psychiatric Disorders 283
Adrenergic Agents 285
Calcium Channel Blockers 287
Dopaminergic Agents 288
GABA-Agents/Anticonvulsants 289
Serotonin Antagonists 291
Opioid Antagonists/Agonists 291
Steroid Biosynthesis Inhibitors 292
Immunomodulators 292
Hormones 292
Miscellaneous 293
Herbal and "Natural" Products 295
Glossary 302
Suggested Readings 306
Patient Information Sheets 313
Index of Drugs 373 |
adam_txt |
Antidepressants 2
Selective Serotonin Reuptake Inhibitors (SSRI) 3
Norepinephrine Dopamine Reuptake Inhibitor
(NDRI) 16
Selective Serotonin Norepinephrine Reuptake
Inhibitor (SNRI) 21
Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) 27
Noradrenergic/Specific Serotonergic
Antidepressants (NaSSA) 33
Non-Selective Cyclic Antidepressants 37
Monoamine Oxidase Inhibitors 46
Reversible Inhibitor of MAO-A (RIMA) 46
Irreversible Monoamine Oxidase Inhibitors 50
Monoamine Oxidase B Inhibitor 56
Effects of Antidepressants on
Neurotransmitters/Receptors 59
Pharmacological Effects of Antidepressants
on Neurotransmitters/Receptors 60
Frequency of Adverse Reactions to Cyclic
Antidepressants at Therapeutic Doses 61
Frequency (%) of Adverse Reactions to MAOI
Antidepressants at Therapeutic Doses 63
Antidepressant Doses and Pharmacokinetics 64
Switching Antidepressants 66
Antidepressant Augmentation Strategies 68
Electroconvulsive Therapy (ECT) 71
Bright-Light Therapy (BLT) 77
Repetitive Transcranial Magnetic
Stimulation (rTMS) 79
Antipsychotics (Neuroleptics) 82
"Second-Generation" Antipsychotics/SGAs
(Neuroleptics) 88
"Third-Generation" Antipsychotic/TGA
(Neuroleptics) 103
"First Generation" Antipsychotics/FGAs 106
Effects of Antipsychotics on
Neurotransmitters/Receptors 117
fABLE of Contents
Pharmacological Effects of Antipsychotics
on Neurotransmitters/Receptors 118
Frequency (%) of Adverse Reactions to
Antipsychotics at Therapeutic Doses 119
Antipsychotic Doses and Pharmacokinetics 121
Comparison of Depot Antipsychotics 126
Extrapyramidal Side Effects of Antipsychotics 128
Switching Antipsychotics 131
Antipsychotic Augmentation Strategies 133
Agents for Treating Extrapyramidal
Side Effects 136
Effects on Extrapyramidal Symptoms 141
Comparison of Agents for Treating
Extrapyramidal Side Effects 142
Anxiolytic Agents 145
Benzodiazepines 145
Comparison of the Benzodiazepines 154
Buspirone 159
Hypnotics/Sedatives 162
Comparison of Hypnotics/Sedatives 168
Mood Stabilizers 173
Lithium 173
Anticonvulsants 182
Comparison of Anticonvulsants 185
Comparison of Adverse Reactions to
Mood Stabilizers at Therapeutic Doses 203
L-Tryptophan 204
Drugs for ADHD 206
Psychostimulants 206
Atomoxetine 214
Comparison of Drugs for ADHD 217
Clonidine 221
Augmentation Strategies in ADHD 224
Drugs for Treatment of Dementia 225
Cholinesterase Inhibitors 225
Memantine 231
Comparison of Drugs for Treatment of Dementia 233
Sex-Drive Depressants 236
Comparison of Sex-Drive Depressants 238
Drugs of Abuse 240
Alcohol 243
Stimulants 247
Hallucinogens 252
Opiates/Narcotics 259
Inhalants/Aerosols 263
Gamma Hydroxy Butyrate (GHB)/Sodium Oxybate 265
Flunitrazepam (Rohypnol) 267
Treatment of Substance Use Disorders 268
Disulfiram 268
Acamprosate 271
Naltrexone 273
Methadone 276
Buprenorphine 280
New Unapproved Treatments
of Psychiatric Disorders 283
Adrenergic Agents 285
Calcium Channel Blockers 287
Dopaminergic Agents 288
GABA-Agents/Anticonvulsants 289
Serotonin Antagonists 291
Opioid Antagonists/Agonists 291
Steroid Biosynthesis Inhibitors 292
Immunomodulators 292
Hormones 292
Miscellaneous 293
Herbal and "Natural" Products 295
Glossary 302
Suggested Readings 306
Patient Information Sheets 313
Index of Drugs 373 |
any_adam_object | 1 |
any_adam_object_boolean | 1 |
author_GND | (DE-588)121257649 |
building | Verbundindex |
bvnumber | BV023107060 |
classification_rvk | CZ 2000 XI 5800 |
ctrlnum | (OCoLC)255600546 (DE-599)DNB985233907 |
dewey-full | 615.788 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.788 |
dewey-search | 615.788 |
dewey-sort | 3615.788 |
dewey-tens | 610 - Medicine and health |
discipline | Psychologie Medizin |
discipline_str_mv | Psychologie Medizin |
edition | 17., completely rev. ed. |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV023107060</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20170705</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">080130s2007 xxud||| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">07,A37,0826</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">985233907</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780889373457</subfield><subfield code="c">spiralgeh. : EUR 54.95</subfield><subfield code="9">978-0-88937-345-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)255600546</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB985233907</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield><subfield code="a">sz</subfield><subfield code="c">XA-CH</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.788</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.788</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CZ 2000</subfield><subfield code="0">(DE-625)19239:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5800</subfield><subfield code="0">(DE-625)153018:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QV 77.2</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical handbook of psychotropic drugs</subfield><subfield code="c">Kalyna Z. Bezchlibnyk-Butler, principal ed. ...</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Psychotropic drugs</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">17., completely rev. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Ashland, OH [u.a.]</subfield><subfield code="b">Hogrefe</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">380 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychopharmakon</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bezchlibnyk-Butler, Kalyna Z.</subfield><subfield code="d">1947-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)121257649</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016309721&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016309721</subfield></datafield></record></collection> |
id | DE-604.BV023107060 |
illustrated | Illustrated |
index_date | 2024-07-02T19:46:57Z |
indexdate | 2024-10-30T11:02:09Z |
institution | BVB |
isbn | 9780889373457 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016309721 |
oclc_num | 255600546 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-578 |
owner_facet | DE-355 DE-BY-UBR DE-578 |
physical | 380 S. graph. Darst. |
publishDate | 2007 |
publishDateSearch | 2007 |
publishDateSort | 2007 |
publisher | Hogrefe |
record_format | marc |
spelling | Clinical handbook of psychotropic drugs Kalyna Z. Bezchlibnyk-Butler, principal ed. ... Psychotropic drugs 17., completely rev. ed. Ashland, OH [u.a.] Hogrefe 2007 380 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Psychopharmakon Psychopharmakon (DE-588)4047729-0 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 s DE-604 Bezchlibnyk-Butler, Kalyna Z. 1947- Sonstige (DE-588)121257649 oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016309721&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Clinical handbook of psychotropic drugs Psychopharmakon Psychopharmakon (DE-588)4047729-0 gnd |
subject_GND | (DE-588)4047729-0 |
title | Clinical handbook of psychotropic drugs |
title_alt | Psychotropic drugs |
title_auth | Clinical handbook of psychotropic drugs |
title_exact_search | Clinical handbook of psychotropic drugs |
title_exact_search_txtP | Clinical handbook of psychotropic drugs |
title_full | Clinical handbook of psychotropic drugs Kalyna Z. Bezchlibnyk-Butler, principal ed. ... |
title_fullStr | Clinical handbook of psychotropic drugs Kalyna Z. Bezchlibnyk-Butler, principal ed. ... |
title_full_unstemmed | Clinical handbook of psychotropic drugs Kalyna Z. Bezchlibnyk-Butler, principal ed. ... |
title_short | Clinical handbook of psychotropic drugs |
title_sort | clinical handbook of psychotropic drugs |
topic | Psychopharmakon Psychopharmakon (DE-588)4047729-0 gnd |
topic_facet | Psychopharmakon |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016309721&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT bezchlibnykbutlerkalynaz clinicalhandbookofpsychotropicdrugs AT bezchlibnykbutlerkalynaz psychotropicdrugs |